title: Where do conventional OADs stand.
abstract: The last two decades have witnessed unprecedented activity in the field of OADs with many new drugs becoming available. Concerns with OAD include cardiovascular safety, fear about hypoglycemia, weight gain etc. In this article we attempt to review OADs , sulfonylureas in particular, in the light of the newer agents.
authors.affiliation: Department of Endocrinology, Osmania Medical College & Hospital, Hyderabad, India.
authors.forename: Rakesh Kumar
authors.initials: RK
authors.lastname: Sahay
authors.forename: V Sri
authors.initials: VS
authors.lastname: Nagesh
keywords: Conventional OADs; new roles; sulfonylureas
references.citation: J Pharmacol Exp Ther. 1993 Dec;267(3):1355-62
references.pmid: 8263798
references.citation: Metabolism. 2008 Aug;57(8):1038-45
references.pmid: 18640379
references.citation: N Engl J Med. 2000 Oct 19;343(16):1134-8
references.pmid: 11036118
references.citation: J Clin Endocrinol Metab. 2003 Feb;88(2):531-7
references.pmid: 12574175
references.citation: Am J Obstet Gynecol. 2005 Jul;193(1):118-24
references.pmid: 16021069
references.citation: Pediatr Res. 2001 Jun;49(6):734
references.pmid: 11385129
references.citation: J Am Coll Cardiol. 1999 Jan;33(1):119-24
references.pmid: 9935017
references.citation: J Matern Fetal Neonatal Med. 2002 Dec;12(6):362-4
references.pmid: 12683645
references.citation: Lancet. 1998 Sep 12;352(9131):837-53
references.pmid: 9742976
references.citation: J Matern Fetal Neonatal Med. 2004 Jan;15(1):51-5
references.pmid: 15101612
references.citation: N Engl J Med. 2008 May 8;358(19):2003-15
references.pmid: 18463376
references.citation: Diabetes Care. 2011 Oct;34(10):2279-84
references.pmid: 21949222
references.citation: Diabetes. 1970;19:Suppl:789-830
references.pmid: 4926376
references.citation: Curr Diab Rep. 2001 Aug;1(1):82-5
references.pmid: 12762962